FDA.reportPublic FDA data

Duolaq

Manufacturer
METHODIQ INC.
Effective date
2025-11-10
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:16:41

Label at a glance#

ProductDuolaq
Active ingredientSALICYLIC ACID
Label structure7 sections

Indications and uses

For the management / treatment of acne. Clears acne blemishes and blackheads. Helps prevent the development of new acne blemishes and blackheads

Dosage and administration

Clean the skin thoroughly before applying this product. Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2%

Purpose

OTC - PURPOSE SECTION

Salicylic Acid 2%................Acne Treatment

Uses

INDICATIONS & USAGE SECTION

  • For the management / treatment of acne.
  • Clears acne blemishes and blackheads.
  • Helps prevent the development of new acne blemishes and blackheads

Warnings

WARNINGS SECTION

For external use only

OTC - WHEN USING SECTION

When using this product
Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.
If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Clean the skin thoroughly before applying this product.
  • Cover the entire affected area with a thin layer one to three times daily.
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
  • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Glycerin, Ammonium Polyacryloyldimethyl Taurate, Propanediol, Sodium Polyacrylate, Butylene Glycol, Pentylene Glycol, Glycolic Acid, Dimethicone, Propylene Glycol, Dimethyl Isosorbide, 4-t-Butylcyclohexanol, Phenoxyethanol, Niacinamide, Xylitol, Caprylic Acid, Caprylyl Glycol, Allantoin, Hexylene Glycol, Ethylhexylglycerin, Chamomilla Recutita (Matricaria) Flower Extract, Hydrolyzed Sodium Hyaluronate, Citric Acid, Glycyrrhiza Glabra (Licorice) Root Powder, Fomes Officinalis (Mushroom) Extract, Camellia Oleifera Leaf Extract, Hydroxyphenyl Propamidobenzoic Acid, Leuconostoc/Radish Root Ferment Filtrate, Ascorbyl Palmitate, Potassium Sorbate, Sodium Benzoate, Triethyl Citrate, Phenethyl Alcohol, 2,6-Dimethyl-7-Octen-2-ol, Benzyl Acetate, Heliotropine, 3-Hexenol, Gamma-Undecalactone.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

15ml

0.5 Fl. Oz.

Duolaq

Salicylic Acid Acne Treatment

11

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
346298salicylic acid 2 % Topical GelPSN1
346298salicylic acid 0.02 MG/MG Topical GelSCD1
346298salicylic acid 2 % Topical GelSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
87110-001-01Duolaq15 mL in 1 BOTTLE, PUMPGEL151
87110-001-01Duolaq1 in 1 CARTONGEL11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 40 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87110-00187110-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 39 matching rows.

Name, UNII, Kind table
NameUNIIKind
LARICIFOMES OFFICINALIS FRUITING BODY7IFM8431X3IACT
PENTYLENE GLYCOL50C1307PZGIACT
DIMETHYL ISOSORBIDESA6A6V432SIACT
4-T-BUTYLCYCLOHEXANOLK0H1405S9CIACT
TRIETHYL CITRATE8Z96QXD6UMIACT
DIMETHICONE92RU3N3Y1OIACT
ALLANTOIN344S277G0ZIACT
NIACINAMIDE25X51I8RD4IACT
GAMMA-UNDECALACTONEQB1T0AG2YLIACT
GLYCOLIC ACID0WT12SX38SIACT
POTASSIUM SORBATE1VPU26JZZ4IACT
CAPRYLIC ACIDOBL58JN025IACT
CAPRYLYL GLYCOL00YIU5438UIACT
CHAMOMILEFGL3685T2XIACT
SODIUM HYALURONATEYSE9PPT4THIACT
CITRIC ACID2968PHW8QPIACT
HYDROXYPHENYL PROPAMIDOBENZOIC ACID25KRT26H77IACT
ASCORBYL PALMITATEQN83US2B0NIACT
HELIOTROPINEKE109YAK00IACT
SALICYLIC ACIDO414PZ4LPZACTIB
WATER059QF0KO0RIACT
GLYCERINPDC6A3C0OXIACT
PHENETHYL ALCOHOLML9LGA7468IACT
GLYCYRRHIZA GLABRA (LICORICE) ROOT POWDER2788Z9758HIACT
CAMELLIA OLEIFERA LEAF5077EL0C60IACT
SODIUM BENZOATEOJ245FE5EUIACT
PROPANEDIOL5965N8W85TIACT
2,6-DIMETHYL-7-OCTEN-2-OL46L1B02ND9IACT
PROPYLENE GLYCOL6DC9Q167V3IACT
BENZYL ACETATE0ECG3V79ZJIACT
XYLITOLVCQ006KQ1EIACT
ETHYLHEXYLGLYCERIN147D247K3PIACT
LEUCONOSTOC/RADISH ROOT FERMENT FILTRATED2QHA03458IACT
3-HEXENOLV14F8G75P4IACT
AMMONIUM POLYACRYLOYLDIMETHYL TAURATEF01RIY4371IACT
SODIUM POLYACRYLATE (8000 MW)285CYO341LIACT
BUTYLENE GLYCOL3XUS85K0RAIACT
PHENOXYETHANOLHIE492ZZ3TIACT
HEXYLENE GLYCOLKEH0A3F75JIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DuolaqSALICYLIC ACIDMETHODIQ INC.4341d931-897d-c298-e063-6394a90a4d6f2025-11-10WarningsExact identifier
ndc (package): 87110-001-01
ndc (product): 87110-001
ndc11 (package): 87110000101
spl id: 4341d931-897e-c298-e063-6394a90a4d6f
spl set id: 4341d931-897d-c298-e063-6394a90a4d6f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.